Cogent Biosciences
COGT
COGT
135 hedge funds and large institutions have $886M invested in Cogent Biosciences in 2023 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 58 increasing their positions, 36 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
0% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 12
15% less capital invested
Capital invested by funds: $1.05B → $886M (-$162M)
Holders
135
Holding in Top 10
7
Calls
$940K
Puts
$275K
Top Buyers
| 1 | +$41.4M | |
| 2 | +$8.13M | |
| 3 | +$6.53M | |
| 4 |
SVCM
Saturn V Capital Management
Austin,
Texas
|
+$6.16M |
| 5 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
+$5.78M |
Top Sellers
| 1 | -$22.2M | |
| 2 | -$12.6M | |
| 3 | -$9.47M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$9.42M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$8.95M |